Photodynamic therapy is a revolutionary treatment aimed at treating cancers without surgery or chemotherapy. It is
based on the discovery that certain chemicals known as photosensitizing agents (e.g. porphyrins, phthalocyanines, etc.)
can kill cancerous cells when exposed to low level laser light at a specific wavelength. The present study investigates
the cellular uptake and photodynamic effect of gallium (III) phthalocyanine chloride (GaPcCl) on Caco-2 cancer cells.
Caco-2 cells were treated with different concentrations of GaPcCl for 2 h before treatment with a diode laser
(λ = 661 nm, laser power = 90 mW) delivering a light dose of 2.5 J/cm2, 4.5 J/cm2 or 8.5 J/cm2. After 24 h, the cell
viability of post-irradiated cells was measured using the MTT assay. Cellular uptake studies were performed by
photosensitizing cells with GaPcCl for 30 min, 2 h, 10 h, 12 h, 18 h and 24 h before lysing the treated cells into solution
to measure the GaPcCl fluorescence emission at an excitation wavelength of 600 nm. Results showed an increase in
fluorescence intensity of emission peaks at longer incubation times, indicating a greater cellular uptake of GaPcCl by
Caco-2 cells at 24 h in comparison to 30 min. GaPcCl at a concentration of 100 μg/ml activated with a laser light dose
of 8.5 J/cm2 reduced the cell viability of Caco-2 cells to 27%. This concludes that GaPcCl activated with low level laser
light can be used as a photosensitizing agent for the in vitro PDT treatment of colon cancer.© (2012) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kaminee Maduray and Bharti Odhav
"Efficacy of gallium phthalocyanine as a photosensitizing agent in
photodynamic therapy for the treatment of cancer", Proc. SPIE 8553, Optics in Health Care and Biomedical Optics V, 85530G (December 11, 2012); doi:10.1117/12.2001266; http://dx.doi.org/10.1117/12.2001266